India's Eris Lifesciences launches generic semaglutide at $13.8 per month
Go back to India's Eris Lifesciences launches generic semaglutide at $13.8 per month| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1183.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1183.46 | 52 Week High | $88.16 | |||
| Open | $1183.46 | 52 Week Low | $67.88 | |||
| Day High | $1183.46 | P/E | 273.95 | |||
| Day Low | $1183.46 | EPS | $4.32 | |||
| Volume | 3,520 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 38.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.80 | 52 Week High | $59.00 | |||
| Open | $38.80 | 52 Week Low | $32.80 | |||
| Day High | $38.80 | P/E | N/A | |||
| Day Low | $38.80 | EPS | $0.00 | |||
| Volume | 137,924 | |||||
